对缺乏可操作突变的非小细胞肺癌的精细化治疗策略:多组研究的见解
Andrea Rocca1, Lucio Crinò2, Luca Braga3
1Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. andrea.rocca@units.it.
British journal of cancer
|August 23, 2025
概括
缺乏可操作的基因组改变的非小细胞肺癌 (NSCLC) 存在治疗挑战. 多组学研究揭示了细胞循环,DNA修复和代谢途径的新脆弱性,指导了新的精确瘤学策略.
科学领域:
- 癌症学
- 基因组学
- 分子生物学
背景情况:
- 非小细胞肺癌 (NSCLC) 具有分子多样性.
- 一些NSCLC具有可操作的基因组改变或对免疫检查点抑制剂作出反应.
- 许多NSCLC缺乏可操作的瘤抑制基因变异.
研究的目的:
- 在没有可操作的基因组改变的情况下审查NSCLC的新兴治疗机会.
- 探索多组学研究的见解,以确定新的治疗策略.
- 为了提高NSCLC患者的精度瘤学.
主要方法:
- 综述多基因组学研究 (基因组学,转录组学,蛋白质组学).
- 对NSCLC分子景观和信号网络的分析.
- 确定不同的瘤亚型和治疗点.
主要成果:
- 没有可操作变化的NSCLC显示细胞循环,DNA修复,免疫,表观遗传,代谢和氧化还原途径的失调.
- 蛋白质基因组方法提高了对分子亚型的理解.
- 在具有TP53,KEAP1,STK11或NF1变化的瘤中发现了新的脆弱性.
结论:
- 多组学数据揭示了NSCLC的新治疗点.
- 了解更广泛的分子景观可以为新药开发和组合策略提供信息.
- 通过针对这些新发现的漏洞,可以提高NSCLC的精确瘤学水平.
更多相关视频
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.2K
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K